A lentiviral vector-based insertional mutagenesis screen identifies mechanisms of resistance to MAPK inhibitors in melanoma

Marco Ranzani (Wellcome Sanger Institute)

Constantine Alifrangis (University College London Hospitals NHS Foundation Trust, Wellcome Sanger Institute)

Nicola A. Thompson (Wellcome Sanger Institute)

Alistair G. Rust (Royal Marsden NHS Foundation Trust, Wellcome Sanger Institute)

Amin Allahyar (TU Delft - Pattern Recognition and Bioinformatics)

Vivek Iyer (Wellcome Sanger Institute)

Stacey Price (Wellcome Sanger Institute)

Peter Ellis (Wellcome Sanger Institute)

Gemma Turner (Wellcome Sanger Institute)

undefined More Authors (External organisation)